[What is assured in therapy with HMG-CoA reductase inhibitors (cholesterol synthesis inhibitors)?].
Knisel
W
W
Abteilung Innere Medizin IV, Medizinische Klinik und Poliklinik, Universität Tübingen.
Eggstein
M
M
D002784:Cholesterol / Q000097:blood; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D006937:Hypercholesterolemia / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D013329:Structure-Activity Relationship
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D002784:Cholesterol
Was ist gesichert in der Therapie mit HMG-CoA-Reduktasehemmern (Cholesterinsynthesehemmern)?